The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review
- PMID: 39684494
- PMCID: PMC11641189
- DOI: 10.3390/ijms252312784
The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review
Abstract
Resolvins are specialized pro-resolving mediators (SPMs) derived from omega-3 fatty acids that play a critical role in resolving inflammation and restoring tissues to a state of health after an immune response. Their role in chronic inflammatory conditions highlights their importance in maintaining a balance between an effective immune response and the resolution of inflammation to prevent tissue damage. Periodontal disease is a chronic inflammatory condition affecting the tissues surrounding the teeth, leading to gum damage and bone loss. Chronic inflammation in periodontal disease can exacerbate systemic inflammation and influence other conditions, such as diabetes. There is a bidirectional relationship between diabetes and periodontal disease, as both are characterized by chronic inflammation and exacerbate systemic and oral health complications. This narrative review aims to synthesize the current knowledge on how resolvins influence inflammatory pathways and the tissue repair mechanism in periodontal disease in patients with type 2 diabetes. Furthermore, this review serves as a foundation for developing targeted therapeutic strategies, addressing the pressing need for effective treatments that consider both systemic and oral health outcomes.
Keywords: inflammation; periodontal disease; resolvins; type 2 diabetes.
Conflict of interest statement
The authors declare no conflicts of interests.
Figures



Similar articles
-
Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.Mol Nutr Food Res. 2020 Feb;64(4):e1900824. doi: 10.1002/mnfr.201900824. Epub 2019 Dec 15. Mol Nutr Food Res. 2020. PMID: 31797565 Review.
-
Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.Int J Mol Sci. 2023 Oct 24;24(21):15528. doi: 10.3390/ijms242115528. Int J Mol Sci. 2023. PMID: 37958514 Free PMC article. Review.
-
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16. Semin Immunol. 2022. PMID: 35227568 Free PMC article. Review.
-
Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders.Int J Mol Sci. 2024 Sep 4;25(17):9598. doi: 10.3390/ijms25179598. Int J Mol Sci. 2024. PMID: 39273541 Free PMC article. Review.
-
Pro-resolving mediators in the regulation of periodontal disease.Mol Aspects Med. 2017 Dec;58:21-36. doi: 10.1016/j.mam.2017.04.006. Epub 2017 May 18. Mol Aspects Med. 2017. PMID: 28483532 Free PMC article. Review.
References
-
- Pia M., Palo D., Rengo C., Fiorino A., Maurotto M., Gavinha Costa L., Manso M.C., Mosley G.A., Campos J., Fernandes H., et al. Correlation between Periodontitis and Gastritis Induced by Helicobacter pylori: A Comprehensive Review. Microorganisms. 2024;12:1579. doi: 10.3390/microorganisms12081579. - DOI - PMC - PubMed
-
- Herrera D., Sanz M., Shapira L., Brotons C., Chapple I., Frese T., Graziani F., Hobbs F.D.R., Huck O., Hummers E., et al. Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe. Eur. J. Gen. Pract. 2024;30:2320120. doi: 10.1080/13814788.2024.2320120. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical